SR-9011 is a synthetic compound known as a Rev-ErbA ligand. It was developed by Professor Thomas Burris and colleagues at The Scripps Research Institute. SR-9011 targets Rev-Erbα and Rev-Erbβ, which are nuclear receptors involved in the regulation of circadian rhythm, metabolism, and energy homeostasis. By binding to these receptors, SR-9011 can influence mitochondrial activity, fat storage, and glucose metabolism — making it a molecule of interest in studies on obesity, endurance, and metabolic disorders.